Role of anti-HLA antibodies whether or not they are directed against the donor during chronic renal graft dysfunction;Rôle des anticorps anti-HLA dirigés contre le donneur ou non au cours de la dysfonction chronique du greffon rénal

Nephrologie et Therapeutique

Volumn 4, Issue SUPPL. 3, 2008, Pages

  Buchler M ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Anti HLA antibodies; Antibody mediated chronic rejection; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOKINE; HLA ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS;

ANTIGEN SPECIFICITY; ARTICLE; DISEASE COURSE; EXPERIMENTAL MOUSE; HEART GRAFT; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY TRANSPLANTATION; NONHUMAN; PATIENT CARE; PLASMAPHERESIS; RENAL GRAFT DYSFUNCTION; VASCULAR DISEASE;

CHRONIC DISEASE; COMBINED MODALITY THERAPY; COMPLEMENT ACTIVATION; CYTOKINES; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; POSTOPERATIVE COMPLICATIONS; PRIMARY GRAFT DYSFUNCTION; PYELONEPHRITIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 55749109161     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1769-7255(08)74235-4     Document Type: Article

References (20)

1. Pelletier R., Hennessy P., Adams P., VanBuskirk A., Ferguson R., and Orosz C. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2 (2002) 134-141
2. Mao Q., Terasaki P., Cai J., Briley K., Catrou P., Haisch C., et al. Extremly high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 7 (2007) 864-871
3. Nickeleit V., Zeiler M., Gudat F., Thiel G., and Mihatsch M. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 13 (2002) 242-251
4. th International HLA and immunogenetics workshop: Report on the prospective chronic rejection project. Tissue Antigens 69 suppl 1 (2007) 174-179
5. Hourmant M., Cesbron-Gautier A., Terasaki P., Mizutani K., Moreau A., Meurette A., et al. Frequency and clinical implications of development of donor-specific and non-donor - pecific HLA antibodies after kidney transplantation. J Am Soc Nephrol 16 (2005) 2804-2812
6. Solez K., Colvin R., Racusen L., Haas M., Sis B., Mengel M., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8 (2008) 753-760
7. Sis B., Campbell P., Mueller T., Hunter C., Cockfield S., Cruz J., et al. Transplant glomerulopathy, late antibody-mediated ejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 7 (2007) 1743-1752
8. Cosio F., Gloor J., Sethi S., and Stegall M. Transplant glomerulopathy. Am J Transplant 8 (2008) 492-496
9. Colvin R. Antibod-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 18 (2007) 1046-1056
10. Buchler M., al Najjar A., Khalfoun B., Gruel Y., Nivet H., Bardos P., et al. Anti-HLA antibodies increase lymphocyte adhesion to allogeneic endothelium. Transplant Proc 27 (1995) 2480-2481
11. Uehara S., Chase C., Cornell L., Madsen J., Russell P., and Colvin R. Chronic cardiac transplant arteriopathy in mice: relationship oof alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 7 (2007) 57-65
12. Mizutani K., Terazaki P., Hamdani E., Esquenazi V., Rosen A., and Ozawa M. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J ransplant 7 (2007) 1027-1031
13. Oliveira J., Monteiro M., Teixeira J., Osorio E., Norton S., Alves H., et al. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment. Transplant Int 18 (2005) 1286-1291
14. Giral M., Pascuariello G., Karam G., Hourmant M., Cantarovitch D., Dantal J., et al. Acute graft pyelonephritis and long term kidney allograft outcome. Kidney Int 61 (2002) 1880-1886
15. Terasaki P., and Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 4 (2004) 438-443
16. Tinckam K., Wood I., Ji F., and Milford E. ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation. Human Immunology 65 (2004) 1281-1287
17. Theruvath T., Saidman S., Mauiyyedi S., Delmonico F., Williams W., Tolkoff-Rubin N., et al. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 72 (2001) 77-83
18. Jordan S., Cunningham-Rundles C., and McEwan R. Utility of intravenous immune globuli in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 3 (2003) 653-664
19. Alkalin E., Sehgal V., and Murphy B. Intravenous Immunoglobulitreatment in a kidney transplant patient with chronic allograft nephropathy. Transplantation 79 (2005) 257-258
20. Faguer S., Kamar N., Guilbeaud-Frugier C., Fort M., Modesto A., Mari A., et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 83 (2007) 1277-1280